Hypoxia News and Research

RSS

Hypoxia is a condition in which there is a decrease in the oxygen supply to a tissue. In cancer treatment, the level of hypoxia in a tumor may help predict the response of the tumor to the treatment.

First 3D multicellular brain organoid can screen drugs to control inflammation

The scientists who developed the first 3D multicellular brain organoid with a functional blood brain barrier now report that the model could be a promising platform to screen drugs that could work to control inflammation, which is at the center of many neurological conditions, like ischemic stroke.

30 Jul 2020

Study shows promise of a major breakthrough in healing chronic diabetic ulcers

A new study released today in STEM CELLS Translational Medicine shows promise of a major breakthrough in healing chronic foot ulcers resulting from diabetes.

28 Jul 2020

New studies indicate the presence of cerebrovascular-neurological dysfunction in COVID-19 patients

As the SARS-CoV-2 virus, or COVID-19 has unfurled its tentacles across the globe, the severe respiratory and pulmonary disorders associated with the infection have become well known.

22 Jul 2020

COVID-19 associated with serious blood clots in leg arteries

COVID-19 is associated with life-threatening blood clots in the arteries of the legs, according to a study published in Radiology.

16 Jul 2020

Evidence of SARS-CoV-2 placental infection in mild COVID-19

Now, a new study published on the preprint server medRxiv* in July 2020 reveals evidence of placental infection and hypoxia, despite the lack of serious symptoms in the mother.

16 Jul 2020

Buck researchers investigate ketone bodies as possible therapeutic against COVID-19

Given the disproportionate impact that COVID-19 has on older adults in terms of death and lasting disability, and the impact of common aging-related comorbidities like diabetes and cardiovascular disease, Buck Institute professor and practicing geriatrician John Newman, MD, PhD, can make a compelling argument that those infected with the SARS-CoV2 virus are suffering from an aging-related disease, no matter how old they are when they get infected.

15 Jul 2020

Baylor Scott & White Research Institute receives NIH award for esophageal cancer study

The incidence of esophageal adenocarcinoma has increased 8-fold over the past 50 years. This is one of the deadliest cancers, with a five-year survival rate of only 20 percent. However, the survival rate more than doubles if the cancer is identified early.

13 Jul 2020

Study provides possible explanations for silent hypoxemia in COVID-19 patients

A new research study provides possible explanations for COVID-19 patients who present with extremely low, otherwise life-threatening levels of oxygen, but no signs of dyspnea (difficulty breathing).

2 Jul 2020

Blood cell damage in COVID-19 may compromise oxygen transport

Researchers in the U.S. have shown that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may alter key protein structures on red blood cells and compromise the transport and delivery of oxygen in patients with coronavirus disease 2019 (COVID-19).

1 Jul 2020

Clinical-grade wearables provide continuous on-body sensing for COVID-19

Although it might be tempting to rely on your fitness tracker to catch early signs of COVID-19, Northwestern University researchers caution that consumer wearables are not sophisticated enough to monitor the complicated illness.

1 Jul 2020

Protein profile in serum reflects COVID-19 severity

The wide range of manifestations of COVID-19 has continued to baffle investigators. Now, a new study published on the preprint server medRxiv in June 2020 shows that blood proteins in COVID-19 patients change over time, and these can possibly predict or reflect the severity of disease. More, they may present targets for treatment.

25 Jun 2020

Abnormal findings in testicular tissue of COVID-19 patients, SARS-CoV-2 mostly undetected

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused over 9.263 million cases and taken more than 477,000 lives as of June 24, 2020 – just six months after the initial outbreak in Wuhan, China, was reported. The illness, called COVID-19 disease, caused by SARS-CoV-2 is a severe pneumonic illness, caused by the entry of the virus into the type II alveolar cells.

24 Jun 2020

Researchers report a key breakthrough to help protect newborns from brain damage

Oxygen deprivation can be the worst start to a newborn's life, resulting in brain damage, epilepsy, developmental delays and death.

23 Jun 2020

Improving cancer therapies by exploiting drug resistance in cancer

News-Medical talks to Professor David Thomas about his recent research identifying the mechanisms behind cancer cells developing resistance to drugs.

23 Jun 2020

Researchers find prothrombotic antibodies in patients with COVID-19

Even as the COVID-19 pandemic continues to spread across the world, researchers are still trying to understand the many ways in which it can manifest and its pathogenesis. A new report published on the preprint server medRxiv* in June 2020 shows that one possible mechanism of disease in COVID-19 is the production of antiphospholipid antibodies.

19 Jun 2020

Genetic marker may predispose African Americans to cardiac complications from COVID-19

Nearly one out of every 10 African Americans has a genetic variant that puts them inherently at an increased risk for ventricular arrhythmias and sudden cardiac death.

15 Jun 2020

Anticardiolipin antibodies and COVID-19

A new study has shown that anticardiolipin antibodies are associated with the novel coronavirus infection or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19.

10 Jun 2020

Octapharma extends support for COVID-19 study following promising preliminary data

Following positive preliminary data, Octapharma USA is extending funding for an investigator-initiated study (IIS) focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation.

3 Jun 2020

ICUs become a ‘delirium factory’ for COVID patients

Doctors are fighting not only to save lives from COVID-19, but also to protect patients' brains.

3 Jun 2020

Silent hypoxia and its role in COVID-19 detection

News-Medical speaks to Dr. Albert Rizzo about silent hypoxia and how it is occurring in individuals that are suffering from COVID-19.

3 Jun 2020

Hypoxia News and Research

Further Reading

First 3D multicellular brain organoid can screen drugs to control inflammation

Study shows promise of a major breakthrough in healing chronic diabetic ulcers

New studies indicate the presence of cerebrovascular-neurological dysfunction in COVID-19 patients

COVID-19 associated with serious blood clots in leg arteries

Evidence of SARS-CoV-2 placental infection in mild COVID-19

Buck researchers investigate ketone bodies as possible therapeutic against COVID-19

Baylor Scott & White Research Institute receives NIH award for esophageal cancer study

Study provides possible explanations for silent hypoxemia in COVID-19 patients

Blood cell damage in COVID-19 may compromise oxygen transport

Clinical-grade wearables provide continuous on-body sensing for COVID-19

Protein profile in serum reflects COVID-19 severity

Abnormal findings in testicular tissue of COVID-19 patients, SARS-CoV-2 mostly undetected

Researchers report a key breakthrough to help protect newborns from brain damage

Improving cancer therapies by exploiting drug resistance in cancer

Researchers find prothrombotic antibodies in patients with COVID-19

Genetic marker may predispose African Americans to cardiac complications from COVID-19

Anticardiolipin antibodies and COVID-19

Octapharma extends support for COVID-19 study following promising preliminary data

ICUs become a ‘delirium factory’ for COVID patients

Silent hypoxia and its role in COVID-19 detection

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News